Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 2Cancer Pain 2Squamous Cell Carcinoma of Head and Neck 1Opioid-Related Disorders 1Neuralgia 1Mucositis 1Lymphoma, Follicular 1

Interventions

Lidocaine 4Oxycodone 2Capsaicin 2ziconotide 1nabiximols 1Vitamin B 6 1Vitamin B 12 1Vinorelbine 1Vincristine 1Transcutaneous Electric Nerve Stimulation 1Transcranial Magnetic Stimulation 1Thalidomide 1Telmisartan 1Tapentadol 1Surveys and Questionnaires 1Sodium Chloride 1Pregabalin 1Plastic Surgery Procedures 1Paclitaxel 1Oxaliplatin 1Morphine 1Methadone 1Manipulation, Osteopathic 1Lidoderm 1Ketamine 1KRN 5500 1Hypnosis 1Hydromorphone 1Geritol 1Gabapentin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neuralgia × Buprenorphine × Clear all
NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Completed
150 enrolled

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡